JADE news

Latest 2 stories · newest Jun 11, 2026

JADE

Jade Biosciences completes conversion from Delaware to Nevada corporation

Aerovate Therapeutics, Inc. converted into a Nevada corporation and renamed Jade Biosciences, Inc. The corporate restructuring updates the company's governing documents and state of incorporation.

Restructuring Jun 11, 2026 sentiment 0.00 SEC filing ↗

JADE

Jade Biosciences prices 10M share offering with Jefferies, TD Cowen, UBS

Jade Biosciences launched an underwritten public offering of 10 million shares of common stock with an additional 1.5 million share overallotment option. The offering provides capital for the bioscience company and is led by major investment banks Jefferies, TD Securities, and UBS Securities.

Offering Jun 4, 2026 sentiment 0.00 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same JADE feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/JADE/newsSTART FREE